What is the intrinsic value of IN.TO?

As of 2025-07-04, the Intrinsic Value of InMed Pharmaceuticals Inc (IN.TO) is -15.53 CAD. This IN.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.19 CAD, the upside of InMed Pharmaceuticals Inc is -470.75%.

Is IN.TO undervalued or overvalued?

Based on its market price of 4.19 CAD and our intrinsic valuation, InMed Pharmaceuticals Inc (IN.TO) is overvalued by 470.75%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-15.53 - -15.53	-15.53	-470.75%
P/E	(15.34) - (18.84)	(15.75)	-475.9%
DDM - Stable	(12.32) - (52.57)	(32.45)	-874.4%
DDM - Multi	(13.50) - (45.66)	(20.94)	-599.9%